|
| Status |
Public on Feb 22, 2022 |
| Title |
WNT11 is a novel ligand for ROR2 in human breast cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Nov 20, 2020 |
| Last update date |
Mar 12, 2022 |
| Contact name |
Darius Wlochowitz |
| E-mail(s) |
darius.wlochowitz@bioinf.med.uni-goettingen.de
|
| Organization name |
Institute of Bioinformatics
|
| Department |
Bioinformatics
|
| Street address |
Goldschmidtstr. 1
|
| City |
Göttingen |
| ZIP/Postal code |
37077 |
| Country |
Germany |
| |
|
| Platforms (2) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
| GPL30173 |
NextSeq 2000 (Homo sapiens) |
|
| Samples (58)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE161864 |
WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer |
| GSE161865 |
WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer [patients] |
|
| Relations |
| BioProject |
PRJNA679735 |
Less...
More...